AtriCure, Inc. Share Price & Technical Analysis
ATRC · $28.82 (-0.62%)
Healthcare / Medical Instruments & Supplies
$28.82
-0.62%
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; mu…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
0% return in May, 4% avg return in past 3 year May month.
-31% return in 2026, 7% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | -16% | -6% | -2% | 0% | – | – | – | – | – | – | – | -31% |
| 25 | 30% | -1% | -17% | -7% | 16% | -4% | 8% | 6% | -3% | -1% | 5% | 13% | 43% |
| 24 | -4% | 2% | -13% | -21% | -7% | -2% | -5% | 23% | 9% | 17% | 9% | -16% | -7% |
| 23 | -4% | -11% | 8% | 6% | 2% | 10% | 13% | -18% | -4% | -20% | 3% | 1% | -15% |
| 22 | -6% | 6% | -6% | -21% | -22% | 0% | 22% | -6% | -13% | 7% | 8% | -3% | -35% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.33B
P/E ratio
—
52W high
$43.18
52W low
$25.52
Volume
5,77,463
Beta
1.28
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is AtriCure, Inc. share price today?
- AtriCure, Inc. (ATRC) last traded around $28.82 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ATRC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ATRC. Download the app for real-time alerts.
- How can I analyze AtriCure, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.